Literature DB >> 18768983

Growth determinants for H5N1 influenza vaccine seed viruses in MDCK cells.

Shin Murakami1, Taisuke Horimoto, Le Quynh Mai, Chairul A Nidom, Hualan Chen, Yukiko Muramoto, Shinya Yamada, Ayaka Iwasa, Kiyoko Iwatsuki-Horimoto, Masayuki Shimojima, Akira Iwata, Yoshihiro Kawaoka.   

Abstract

H5N1 influenza A viruses are exacting a growing human toll, with more than 240 fatal cases to date. In the event of an influenza pandemic caused by these viruses, embryonated chicken eggs, which are the approved substrate for human inactivated-vaccine production, will likely be in short supply because chickens will be killed by these viruses or culled to limit the worldwide spread of the infection. The Madin-Darby canine kidney (MDCK) cell line is a promising alternative candidate substrate because it supports efficient growth of influenza viruses compared to other cell lines. Here, we addressed the molecular determinants for growth of an H5N1 vaccine seed virus in MDCK cells, revealing the critical responsibility of the Tyr residue at position 360 of PB2, the considerable requirement for functional balance between hemagglutinin (HA) and neuraminidase (NA), and the partial responsibility of the Glu residue at position 55 of NS1. Based on these findings, we produced a PR8/H5N1 reassortant, optimized for this cell line, that derives all of its genes for its internal proteins from the PR8(UW) strain except for the NS gene, which derives from the PR8(Cambridge) strain; its N1 NA gene, which has a long stalk and derives from an early H5N1 strain; and its HA gene, which has an avirulent-type cleavage site sequence and is derived from a circulating H5N1 virus. Our findings demonstrate the importance and feasibility of a cell culture-based approach to producing seed viruses for inactivated H5N1 vaccines that grow robustly and in a timely, cost-efficient manner as an alternative to egg-based vaccine production.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768983      PMCID: PMC2573193          DOI: 10.1128/JVI.00970-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Amino acid sequence identity between the HA1 of influenza A (H3N2) viruses grown in mammalian and primary chick kidney cells.

Authors:  J M Katz; R G Webster
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

2.  An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure.

Authors:  X Y Qian; C Y Chien; Y Lu; G T Montelione; R M Krug
Journal:  RNA       Date:  1995-11       Impact factor: 4.942

3.  Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection.

Authors:  T Ito; Y Suzuki; A Takada; A Kawamoto; K Otsuki; H Masuda; M Yamada; T Suzuki; H Kida; Y Kawaoka
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  A system for functional analysis of Ebola virus glycoprotein.

Authors:  A Takada; C Robison; H Goto; A Sanchez; K G Murti; M A Whitt; Y Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Safe administration of influenza vaccine to patients with egg allergy.

Authors:  J M James; R S Zeiger; M R Lester; M B Fasano; J E Gern; L E Mansfield; H J Schwartz; H A Sampson; H H Windom; S B Machtinger; S Lensing
Journal:  J Pediatr       Date:  1998-11       Impact factor: 4.406

6.  An 18-amino acid deletion in an influenza neuraminidase.

Authors:  M C Els; G M Air; K G Murti; R G Webster; W G Laver
Journal:  Virology       Date:  1985-04-30       Impact factor: 3.616

7.  Cytopathic effect inhibition assay for canine interferon activity.

Authors:  A Iwata; N M Iwata; T Saito; K Hamada; Y Sokawa; S Ueda
Journal:  J Vet Med Sci       Date:  1996-01       Impact factor: 1.267

8.  Host cell-mediated variation in H3N2 influenza viruses.

Authors:  J M Katz; C W Naeve; R G Webster
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

9.  Biologic importance of neuraminidase stalk length in influenza A virus.

Authors:  M R Castrucci; Y Kawaoka
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  A single amino acid in the PB2 gene of influenza A virus is a determinant of host range.

Authors:  E K Subbarao; W London; B R Murphy
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more
  18 in total

Review 1.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  A novel bivalent vaccine based on a PB2-knockout influenza virus protects mice from pandemic H1N1 and highly pathogenic H5N1 virus challenges.

Authors:  Ryuta Uraki; Maki Kiso; Kiyoko Iwatsuki-Horimoto; Satoshi Fukuyama; Emi Takashita; Makoto Ozawa; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2013-05-08       Impact factor: 5.103

3.  Engineering temperature sensitive live attenuated influenza vaccines from emerging viruses.

Authors:  Bin Zhou; Yan Li; Scott D Speer; Anju Subba; Xudong Lin; David E Wentworth
Journal:  Vaccine       Date:  2012-03-24       Impact factor: 3.641

4.  Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling.

Authors:  Danyel Evseev; Domingo Miranzo-Navarro; Ximena Fleming-Canepa; Robert G Webster; Katharine E Magor
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

5.  The pH of activation of the hemagglutinin protein regulates H5N1 influenza virus pathogenicity and transmissibility in ducks.

Authors:  Mark L Reed; Olga A Bridges; Patrick Seiler; Jeong-Ki Kim; Hui-Ling Yen; Rachelle Salomon; Elena A Govorkova; Robert G Webster; Charles J Russell
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

6.  The source of the PB1 gene in influenza vaccine reassortants selectively alters the hemagglutinin content of the resulting seed virus.

Authors:  Joanna C A Cobbin; Erin E Verity; Brad P Gilbertson; Steven P Rockman; Lorena E Brown
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

7.  An MDCK cell culture-derived formalin-inactivated influenza virus whole-virion vaccine from an influenza virus library confers cross-protective immunity by intranasal administration in mice.

Authors:  Ahmad M Haredy; Nobuyuki Takenaka; Hiroshi Yamada; Yoshihiro Sakoda; Masatoshi Okamatsu; Naoki Yamamoto; Takeshi Omasa; Hisao Ohtake; Yasuko Mori; Hiroshi Kida; Koichi Yamanishi; Shigefumi Okamoto
Journal:  Clin Vaccine Immunol       Date:  2013-05-01

8.  The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets.

Authors:  Hirotaka Imai; Kyoko Shinya; Ryo Takano; Maki Kiso; Yukiko Muramoto; Saori Sakabe; Shin Murakami; Mutsumi Ito; Shinya Yamada; Mai Thi Quynh Le; Chairul A Nidom; Yuko Sakai-Tagawa; Kei Takahashi; Yasuyuki Omori; Takeshi Noda; Masayuki Shimojima; Satoshi Kakugawa; Hideo Goto; Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  PLoS Pathog       Date:  2010-09-16       Impact factor: 6.823

9.  Adaptation of high-growth influenza H5N1 vaccine virus in Vero cells: implications for pandemic preparedness.

Authors:  Yu-Fen Tseng; Alan Yung-Chih Hu; Mei-Liang Huang; Wei-Zhou Yeh; Tsai-Chuan Weng; Yu-Shuan Chen; Pele Chong; Min-Shi Lee
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

10.  Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses.

Authors:  Shixia Wang; Anthony Hackett; Na Jia; Chunhua Zhang; Lu Zhang; Chris Parker; An Zhou; Jun Li; Wu-Chun Cao; Zuhu Huang; Yan Li; Shan Lu
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.